Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Brain Neoplasms 7Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Gliosarcoma 5Polycythemia Vera 4Meningioma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Neoplasms 3Leukemia 3Laryngeal Neoplasms 3Glioma 3Thrombocythemia, Essential 2Primary Myelofibrosis 2Pharyngeal Neoplasms 2Paranasal Sinus Neoplasms 2Myelodysplastic Syndromes 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Squamous Cell 2Tongue Neoplasms 1Thrombosis 1Thrombocytosis 1Stomach Neoplasms 1Salivary Gland Neoplasms 1Recurrence 1Polycythemia 1Papillomavirus Infections 1

Interventions

Rituximab 7Valganciclovir 5Valacyclovir 3Gemcitabine 3Dexamethasone 3Cisplatin 3spartalizumab 2pegaspargase 2Radiotherapy, Intensity-Modulated 2Methylprednisolone 2Lenalidomide 2Etoposide 2Doxorubicin 2Cell Count 2Blood Specimen Collection 2valomaciclovir 1toripalimab 1ruxolitinib 1pembrolizumab 1merphos 1fludarabine 1dehydroftorafur 1avelumab 1apatinib 1Zidovudine 1Watchful Waiting 1Valproic Acid 1Vaccines 1Tenofovir 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Epstein-Barr Virus Infections × Hydroxyurea × Clear all
NCT01964755 2019-09-23

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

University of Miami

Phase 2 Terminated
6 enrolled 14 charts
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡